• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环游离 DNA 下一代测序中误差的随机性。

The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA.

机构信息

Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

ARUP Laboratories, Salt Lake City, Utah, United States of America.

出版信息

PLoS One. 2020 Feb 21;15(2):e0229063. doi: 10.1371/journal.pone.0229063. eCollection 2020.

DOI:10.1371/journal.pone.0229063
PMID:32084206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7034809/
Abstract

Challenges with distinguishing circulating tumor DNA (ctDNA) from next-generation sequencing (NGS) artifacts limits variant searches to established solid tumor mutations. Here we show early and random PCR errors are a principal source of NGS noise that persist despite duplex molecular barcoding, removal of artifacts due to clonal hematopoiesis of indeterminate potential, and suppression of patterned errors. We also demonstrate sample duplicates are necessary to eliminate the stochastic noise associated with NGS. Integration of sample duplicates into NGS analytics may broaden ctDNA applications by removing NGS-related errors that confound identification of true very low frequency variants during searches for ctDNA without a priori knowledge of specific mutations to target.

摘要

从下一代测序(NGS)伪影中区分循环肿瘤 DNA(ctDNA)的挑战限制了变体搜索仅限于已建立的实体瘤突变。在这里,我们表明早期和随机 PCR 错误是 NGS 噪声的主要来源,尽管采用了双链分子条形码、去除由于不确定潜能克隆性造血引起的伪影以及抑制模式错误,这些噪声仍然存在。我们还证明了需要重复样本以消除与 NGS 相关的随机噪声。将重复样本整合到 NGS 分析中,可以通过消除与 NGS 相关的错误来扩大 ctDNA 的应用范围,这些错误在没有针对特定突变的先验知识的情况下,会混淆对 ctDNA 中真正极低频率变体的识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/54c6deae0d4d/pone.0229063.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/edea514a79e7/pone.0229063.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/b22af3f4582a/pone.0229063.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/0eab4ff134f0/pone.0229063.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/54c6deae0d4d/pone.0229063.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/edea514a79e7/pone.0229063.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/b22af3f4582a/pone.0229063.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/0eab4ff134f0/pone.0229063.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/7034809/54c6deae0d4d/pone.0229063.g004.jpg

相似文献

1
The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA.循环游离 DNA 下一代测序中误差的随机性。
PLoS One. 2020 Feb 21;15(2):e0229063. doi: 10.1371/journal.pone.0229063. eCollection 2020.
2
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma.使用下一代测序技术进行无肿瘤信息搜索的循环肿瘤 DNA 检测是胰腺导管腺癌的一种预后生物标志物。
Neoplasia. 2021 Sep;23(9):859-869. doi: 10.1016/j.neo.2021.06.005. Epub 2021 Jul 21.
3
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.通过游离循环肿瘤DNA的下一代测序检测肺癌患者中可治疗靶向的驱动和耐药突变
Clin Cancer Res. 2016 Dec 1;22(23):5772-5782. doi: 10.1158/1078-0432.CCR-16-1231. Epub 2016 Sep 6.
4
Molecular Barcode Sequencing for Highly Sensitive Detection of Circulating Tumor DNA in Patients with Esophageal Squamous Cell Carcinoma.基于分子条码测序的食管鳞癌患者循环肿瘤 DNA 高灵敏度检测
Oncology. 2020;98(4):222-229. doi: 10.1159/000504808. Epub 2019 Dec 17.
5
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.早期和晚期乳腺癌血浆中循环肿瘤 DNA 的超高深度靶向测序。
Cancer Sci. 2021 Jan;112(1):454-464. doi: 10.1111/cas.14697. Epub 2020 Nov 4.
6
Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.基于下一代测序的肿瘤组织与循环肿瘤 DNA 之间基因组改变的相关性。
J Cancer Res Clin Oncol. 2018 Nov;144(11):2167-2175. doi: 10.1007/s00432-018-2747-9. Epub 2018 Sep 10.
7
Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.开发并验证一种用于识别非小细胞肺癌临床可操作突变的循环肿瘤 DNA 检测方法。
Genes Chromosomes Cancer. 2018 Apr;57(4):211-220. doi: 10.1002/gcc.22522. Epub 2018 Jan 30.
8
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics.肝细胞癌下一代测序分析组织和循环肿瘤 DNA:对靶向治疗的影响。
Mol Cancer Ther. 2018 May;17(5):1114-1122. doi: 10.1158/1535-7163.MCT-17-0604. Epub 2018 Feb 26.
9
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.胃食管腺癌的循环肿瘤 DNA 测序分析。
Clin Cancer Res. 2019 Dec 1;25(23):7098-7112. doi: 10.1158/1078-0432.CCR-19-1704. Epub 2019 Aug 19.
10
Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.利用数字下一代测序技术检测胰腺癌患者的循环肿瘤 DNA。
J Mol Diagn. 2020 Jun;22(6):748-756. doi: 10.1016/j.jmoldx.2020.02.010. Epub 2020 Mar 20.

引用本文的文献

1
Predicting high confidence ctDNA somatic variants with ensemble machine learning models.使用集成机器学习模型预测高置信度的ctDNA体细胞变异
Sci Rep. 2025 May 26;15(1):18384. doi: 10.1038/s41598-025-01326-2.
2
Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas.亚克隆癌症驱动突变在成人弥漫性神经胶质瘤未切除的瘤周水肿中普遍存在。
Cancer Res. 2024 Apr 1;84(7):1149-1164. doi: 10.1158/0008-5472.CAN-23-2557.
3
Mitochondrial point heteroplasmy: insights from deep-sequencing of human replicate samples.

本文引用的文献

1
Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing.独特的、双索引测序接头与 UMIs 有效地消除了索引串扰,显著提高了大规模平行测序的灵敏度。
BMC Genomics. 2018 Jan 8;19(1):30. doi: 10.1186/s12864-017-4428-5.
2
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.系统发育ctDNA分析描绘了早期肺癌的演变。
Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364.
3
Integrating liquid biopsies into the management of cancer.
线粒体点异质性:来自人类重复样本深度测序的见解。
BMC Genomics. 2024 Jan 10;25(1):48. doi: 10.1186/s12864-024-09963-z.
4
Isometric artifacts from polymerase chain reaction-massively parallel sequencing analysis of short tandem repeat loci: An emerging issue from a new technology?聚合酶链反应-大规模平行测序分析短串联重复序列位点的等距伪影:新技术带来的新问题?
Electrophoresis. 2022 Jul;43(13-14):1521-1530. doi: 10.1002/elps.202100143. Epub 2022 May 11.
5
Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays.实时数字聚合酶链反应(PCR)作为一项新技术,提高了稀有等位基因检测的检测限。
Transl Lung Cancer Res. 2021 Dec;10(12):4336-4352. doi: 10.21037/tlcr-21-728.
6
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?利用循环肿瘤 DNA 的片段长度,通过下一代测序提高实体瘤恶性肿瘤的分子谱分析:精准肿瘤学中先进的非侵入性诊断的途径?
Mol Diagn Ther. 2021 Jul;25(4):389-408. doi: 10.1007/s40291-021-00534-6. Epub 2021 May 20.
将液体活检纳入癌症管理中。
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548. doi: 10.1038/nrclinonc.2017.14. Epub 2017 Mar 2.
4
Monitoring Error Rates In Illumina Sequencing.监测Illumina测序中的错误率。
J Biomol Tech. 2016 Dec;27(4):125-128. doi: 10.7171/jbt.16-2704-002. Epub 2016 Sep 16.
5
Integrated digital error suppression for improved detection of circulating tumor DNA.用于改善循环肿瘤DNA检测的集成数字误差抑制
Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.
6
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.通过全基因组甲基化测序进行血浆DNA组织图谱分析,用于无创产前、癌症和移植评估。
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):E5503-12. doi: 10.1073/pnas.1508736112. Epub 2015 Sep 21.
7
High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients.使用条形码序列鉴定单个分子的高保真靶向测序:癌症患者血浆游离DNA中突变的从头检测和绝对定量。
DNA Res. 2015 Aug;22(4):269-77. doi: 10.1093/dnares/dsv010. Epub 2015 Jun 29.
8
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.意义未明的克隆性造血及其与骨髓增生异常综合征的鉴别
Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30.
9
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.
10
Detecting ultralow-frequency mutations by Duplex Sequencing.通过双链测序检测超低频突变。
Nat Protoc. 2014 Nov;9(11):2586-606. doi: 10.1038/nprot.2014.170. Epub 2014 Oct 9.